Breaking News Instant updates and real-time market news.

CEMP

Cempra

$3.85

-0.025 (-0.65%)

08:57
08/09/17
08/09
08:57
08/09/17
08:57

Cempra subsidiary to merge with Melinta Therapeutics

Cempra and Melinta Therapeutics announced that the companies have entered into a definitive agreement under which Melinta will merge with a subsidiary of Cempra. The merger is expected to create a NASDAQ-listed company committed to discovering, developing and commercializing important anti-infective therapies for patients and physicians in areas of significant unmet need. "The combined company's extensive pipeline, including commercial, clinical and preclinical stage anti-infective programs with multiple products in development across several indications, provides an exceptional platform to deliver potential long-term growth and value for shareholders," said David Zaccardelli, Pharm.D., acting chief executive officer of Cempra. On a pro forma basis, and based upon the number of shares of Cempra common stock to be issued in the merger, current Cempra shareholders will own approximately 48 percent of the combined company and current Melinta shareholders will own approximately 52 percent of the combined company. The transaction has been approved by the board of directors of both companies. The merger is expected to close in the fourth quarter of 2017, subject to the approval of the stockholders of each company as well as other customary conditions. The combined company, which will be named Melinta Therapeutics, will bring together a deep bench of management talent from both companies. The board of directors of the combined company will have nine seats, with four appointed by Cempra and four appointed by Melinta, together with a newly appointed CEO. Cempra and Melinta will work together through a joint selection committee to identify the CEO leadership of the combined company, who will be able to build on strong experience and the shared vision of the board to continue growing one of the world's leading anti-infectives companies. Melinta will designate the Chairman of the combined company board.

  • 09

    Aug

CEMP Cempra
$3.85

-0.025 (-0.65%)

07/20/17
CANT
07/20/17
NO CHANGE
Target $50
CANT
Overweight
Paratek Pharmaceuticals recent selloff overdone, says Cantor
Cantor Fitzgerald analyst Louise Chen says the two day selloff in shares of Paratek Pharmaceuticals (PRTK) after "positive and competitive" data from the company's OASIS-2 trials is overdone. The issues experienced by Cempra's (CEMP) community antibiotic product are entirely product-specific and not a read-through to Paratek, Chen told investors last night in a research note. She believes Paratek will be able to market Omadacycline effectively if it is approved and keeps an Overweight rating on the shares with a $50 price target.
03/29/17
03/29/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Dunkin' Brands (DNKN) downgraded to Sell from Neutral at Goldman with analyst Karen Holthouse saying with the stock trading at the high end of its valuation range, comp and unit growth risks in the U.S. present downside risk. 2. Darden (DRI) downgraded to Neutral from Buy at BTIG with analyst Peter Saleh saying he does not expect the acquisition to start meaningfully contributing to sales and restaurant profit growth until fiscal 2019/2020 and sees limited upside at current levels. 3. Cempra (CEMP) downgraded to Sell from Hold at Gabelli with analyst Kevin Kedra saying the company is exploring strategic options but expects valuation to diminish along with the company's balance sheet over time and sees little reason to own shares without a catalyst. 4. PPL Corp. (PPL) downgraded to Neutral from Buy at UBS. 5. Panera Bread (PNRA) downgraded to Hold from Buy at Maxim with analyst Stephen Anderson saying he now sees the stock reflecting the positives of continued momentum from "Panera 2.0," opportunities for margin expansion, unit development, and share buybacks following its 25% year-to-date advance. He keeps a $260 price target on Panera shares. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/29/17
GABE
03/29/17
DOWNGRADE
GABE
Sell
Cempra downgraded to Sell from Hold at Gabelli
Gabelli analyst Kevin Kedra downgraded Cemptra to Sell with a price target of $3.75. The analyst said the company is exploring strategic options but expects valuation to diminish along with the company's balance sheet over time and sees little reason to own shares without a catalyst.
03/01/17
JANY
03/01/17
NO CHANGE
Target $5
JANY
Neutral
Cempra likely to trade below cash until FDA gives clarity, says Janney Capital
Janney Capital analyst Debjit Chattopadhyay said that until Cempra has clarity from the FDA on the "once promising" SoliThera, which is not expected until the third quarter of this year, that its shares are likely to trade below cash. He lowered his fair value estimate on Cempra shares to $5 from $8 based on the lack of regulatory and commercial visibility and keeps a Neutral rating on the name.

TODAY'S FREE FLY STORIES

MDT

Medtronic

$83.52

0.11 (0.13%)

, COTY

Coty

$19.55

0.32 (1.66%)

20:25
08/21/17
08/21
20:25
08/21/17
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

MDT

Medtronic

$83.52

0.11 (0.13%)

COTY

Coty

$19.55

0.32 (1.66%)

TOL

Toll Brothers

$38.26

0.11 (0.29%)

DSW

DSW

$15.69

-0.15 (-0.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 22

    Aug

  • 22

    Aug

  • 22

    Aug

  • 22

    Aug

  • 06

    Sep

  • 20

    Sep

ENR

Energizer

$41.24

-0.09 (-0.22%)

18:58
08/21/17
08/21
18:58
08/21/17
18:58
Hot Stocks
Energizer CEO acquires 12,112 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HOMB

Home Bancshares

$23.51

0.11 (0.47%)

, SGBK

Stonegate Bank

$46.70

0.34 (0.73%)

18:41
08/21/17
08/21
18:41
08/21/17
18:41
Hot Stocks
Home Bancshares receives regulatory approvals for merger with Stonegate Bank »

Home BancShares (HOMB)…

HOMB

Home Bancshares

$23.51

0.11 (0.47%)

SGBK

Stonegate Bank

$46.70

0.34 (0.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

ADP

ADP

$102.89

-1.52 (-1.46%)

18:32
08/21/17
08/21
18:32
08/21/17
18:32
Periodicals
ADP CEO: Ackman refused to meet because he needed 'leverage,' CNBC says »

After ADP said its board…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

TWX

Time Warner

$102.11

0.92 (0.91%)

, SNAP

Snap

$13.58

-0.43 (-3.07%)

18:18
08/21/17
08/21
18:18
08/21/17
18:18
Periodicals
CNN begins streaming daily news show on Snapchat, Reuters reports »

CNN, which is owned by…

TWX

Time Warner

$102.11

0.92 (0.91%)

SNAP

Snap

$13.58

-0.43 (-3.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 24

    Aug

  • 13

    Sep

KKR

KKR

18:11
08/21/17
08/21
18:11
08/21/17
18:11
Hot Stocks
Breaking Hot Stocks news story on KKR »

ValueAct raises stake in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BZUN

Baozun

$34.60

0.62 (1.82%)

18:05
08/21/17
08/21
18:05
08/21/17
18:05
Hot Stocks
Baozun reports Q2 Total Gross Merchandise Volume RMB3.604B »

An increase of 63.5%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

BZUN

Baozun

$34.60

0.62 (1.82%)

18:03
08/21/17
08/21
18:03
08/21/17
18:03
Earnings
Baozun sees Q3 revenue RMB870M-RMB910M »

The company will begin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

BZUN

Baozun

$34.60

0.62 (1.82%)

18:02
08/21/17
08/21
18:02
08/21/17
18:02
Earnings
Breaking Earnings news story on Baozun »

Baozun reports Q2…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

BZUN

Baozun

$34.60

0.62 (1.82%)

18:01
08/21/17
08/21
18:01
08/21/17
18:01
Earnings
Baozun reports Q2 EPS 8c, consensus 10c »

Reports Q2 revenue $131M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

KKR

KKR

18:00
08/21/17
08/21
18:00
08/21/17
18:00
Periodicals
KKR near 'clinching' $3B commitment from NYC pension system, Bloomberg says »

KKR is getting close to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESV

Ensco

$4.19

-0.09 (-2.10%)

, NBL

Noble Energy

$23.54

-0.11 (-0.47%)

17:56
08/21/17
08/21
17:56
08/21/17
17:56
Hot Stocks
Ensco awarded contract by Noble Energy »

Ensco (ESV) announced…

ESV

Ensco

$4.19

-0.09 (-2.10%)

NBL

Noble Energy

$23.54

-0.11 (-0.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

  • 05

    Oct

GDOT

Green Dot

$46.58

0.31 (0.67%)

17:51
08/21/17
08/21
17:51
08/21/17
17:51
Hot Stocks
Breaking Hot Stocks news story on Green Dot »

Harvest Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RT

Ruby Tuesday

$1.84

-0.06 (-3.16%)

, RIG

Transocean

$7.32

-0.16 (-2.14%)

17:46
08/21/17
08/21
17:46
08/21/17
17:46
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS: Ruby…

RT

Ruby Tuesday

$1.84

-0.06 (-3.16%)

RIG

Transocean

$7.32

-0.16 (-2.14%)

NDSN

Nordson

$125.12

0.99 (0.80%)

FN

Fabrinet

$39.82

-0.26 (-0.65%)

TEDU

Tarena

$18.61

0.59 (3.27%)

ZAYO

Zayo Group

$32.97

-0.08 (-0.24%)

PINC

Premier

$32.78

-0.16 (-0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 21

    Aug

  • 21

    Aug

  • 21

    Aug

  • 21

    Aug

  • 22

    Aug

  • 29

    Aug

  • 29

    Aug

  • 05

    Sep

  • 06

    Sep

  • 06

    Dec

RIG

Transocean

$7.32

-0.16 (-2.14%)

17:41
08/21/17
08/21
17:41
08/21/17
17:41
Hot Stocks
Transocean director acquires 2,000 registered shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

RDN

Radian Group

$16.46

-0.26 (-1.56%)

17:38
08/21/17
08/21
17:38
08/21/17
17:38
Hot Stocks
Radian Group CEO Thornberry buys 15,000 shares »

Radian Group CEO Richard…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RT

Ruby Tuesday

$1.84

-0.06 (-3.16%)

17:38
08/21/17
08/21
17:38
08/21/17
17:38
Earnings
Ruby Tuesday reports Q4 adjusted EPS 6c vs 10c last year »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 06

    Dec

SRNE

Sorrento Therapeutics

$1.70

-0.05 (-2.86%)

17:29
08/21/17
08/21
17:29
08/21/17
17:29
Hot Stocks
Sorrento closes transactions contemplated by contribution pact with Celularity »

Sorrento Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

GPN

Global Payments

$94.57

0.81 (0.86%)

17:24
08/21/17
08/21
17:24
08/21/17
17:24
Hot Stocks
Global Payments Chairman William Jacobs sells 8,428 shares of company stock »

Global Payments Chairman…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOC

Northrop Grumman

$267.70

0.09 (0.03%)

17:19
08/21/17
08/21
17:19
08/21/17
17:19
Hot Stocks
Northrop Grumman awarded $328.6M government contract »

Northrop Grumman Systems…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

BA

Boeing

$235.68

-0.09 (-0.04%)

17:18
08/21/17
08/21
17:18
08/21/17
17:18
Hot Stocks
Boeing awarded $349.2M government contract »

The Boeing Co.,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMT

Lockheed Martin

$301.88

2.68 (0.90%)

17:17
08/21/17
08/21
17:17
08/21/17
17:17
Hot Stocks
Lockheed Martin awarded $427M government contract »

Lockheed Martin Corp.,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

PBFX

PBF Logistics

$20.80

-0.05 (-0.24%)

17:11
08/21/17
08/21
17:11
08/21/17
17:11
Hot Stocks
Breaking Hot Stocks news story on PBF Logistics »

Carlos Slim reports 5.1%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VZ

Verizon

$48.14

0.45 (0.94%)

17:10
08/21/17
08/21
17:10
08/21/17
17:10
Periodicals
Yahoo owes $5.5M to SCA Promotions after backing out of contract, Reuters says »

The 5th U.S. Circuit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Aug

  • 31

    Aug

  • 06

    Sep

  • 19

    Sep

XOM

Exxon Mobil

$76.38

-0.26 (-0.34%)

17:07
08/21/17
08/21
17:07
08/21/17
17:07
Hot Stocks
Exxon Mobil says fire at a refinery in Botlek, Rotterdam 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.